GleamWall
中文EN

APHD VERDE BIO HOLDINGS, INC.

Crude Petroleum & Natural Gas · OTC · SEC CIK 1490054 · Fiscal year ends 04/30

Financial factors as of 2024-01-31 (2024Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-45.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-190.1%
ROA-85.1%
ROIC (approx.)-83.9%
Asset turnover—

Leverage & solvency

Liabilities / assets84.8%
Debt / equity0.00x
Current ratio—
Interest coverage-38.29x

Cash quality & payout

Operating cash flow / net income0.42x
Accruals ratio-49.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2024Q32024-01-312024Q22023-10-312024Q12023-07-312023Q4*2023-04-302023Q32023-01-312023Q22022-10-312023Q12022-07-312022Q4*2022-04-30
Income statement
Revenue————————
SG&A expense$206,944———$235,535———
Operating income-$410,490-$303,328-$326,953-$402,013-$414,177-$125,275-$698,461-$420,515
Interest expense$0$10,834$728$26,116$9,699$2,716$27,347$0
Pretax income-$1.49M——-$440,344-$439,836———
Net income-$1.49M-$350,826-$336,648-$460,619-$439,836-$154,316-$786,617-$436,918
EBITDA-$395,008-$287,845-$224,014-$411,703-$398,694-$109,793-$683,327-$400,921
EPS (basic)0.00———0.00———
EPS (diluted)0.00———0.00———
Weighted avg. shares (diluted)1.86B———1.37B———
Balance sheet
Cash & equivalents$11,561$39,975$200,265$25,836$50,063$77,665$101,110$141,206
Receivables$53,077——$71,912————
Current assets$104,378$111,164$294,751$97,748$165,309$224,554$262,342$295,873
PP&E, net$1.08M$2.69M$2.71M$2.72M$2.74M$2.76M$2.77M$2.78M
Total assets$1.88M$3.70M$3.94M$4.16M$4.33M$4.67M$4.89M$5.09M
Current liabilities———$1.84M$1.58M$1.56M$1.70M$1.45M
Total liabilities$1.60M$2.01M$1.92M$1.84M$1.58M$1.56M$1.71M$1.47M
Shareholders' equity$119,018$1.54M$1.89M$2.21M$2.66M$3.05M$3.14M$3.59M
Shares outstanding1.93B1.76B1.68B1.54B1.42B1.32B1.28B1.18B
Cash flow statement
Operating cash flow-$314,334-$240,290-$388,585-$155,208-$306,542$16,635-$427,111-$8,848
Capital expenditure$68,881$0$0$0$0$0$6,985$193,076
Free cash flow-$383,215-$240,290-$388,585-$155,208-$306,542$16,635-$434,096-$201,924
Investing cash flow$150,000$0$329,869$0$175,000-$20,000-$6,985-$561,076
Financing cash flow$135,920$80,000$233,145$130,981$103,940-$20,080$394,000-$1
Depreciation & amortization$15,482$15,483$102,939-$9,690$15,483$15,482$15,134$19,594

Free plan shows the latest 8 periods; Pro shows all 56 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.